The second annual Global Rheumatology Summit focused on climate change, conflict and migration, as well as other global issues in rheumatology.

The second annual Global Rheumatology Summit focused on climate change, conflict and migration, as well as other global issues in rheumatology.
Systemic lupus erythematosus (SLE) affects a substantial number of patients worldwide, with an estimated prevalence in North America of 241 per 100,000 people.1 The morbidity and mortality associated with the condition can be significant, and thus research on this disease continues to be of utmost importance. The story of one of the world’s leading experts…
Jonathan T. Cheah, MBBS |
Tumoral Calcinosis in Systemic Sclerosis Plain radiograph and computed tomography images depict calcinosis in the region of the right shoulder, left elbow and cervical spine of a 71-year-old woman with a 20-year history of systemic sclerosis. Manifestations include high-titer anti-Scl-70 antibody, diffuse skin involvement, Raynaud’s syndrome, acro-osteolysis, gastroesophageal reflux disease, interstitial lung disease and complete…
In 1949, the first description of patients with rheumatoid arthritis (RA) given cortisone sent shockwaves through the medical community, quickly capturing the public imagination as well. The paradigm-shifting report paved the way for the use of cortisone and related drugs in RA and many other medical conditions.1 The following is a discussion of some of…
Happy New Year, readers of The Rheumatologist! As the incoming editor, I want to welcome you back in this new year and hope that you’ll stick around, month after month, as we journey together through 2023. As the year progresses, you may notice some departures from what we have previously done, but I also wish…
The COVID-19 Global Rheumatology Alliance Steering Committee: Jinoos Yazdany, MD, MPH; Zachary S. Wallace, MD, MSc; Paul Sufka, MD; Emily Sirotich, PhD; Pedro Machado, MD, PhD, FRCP; Jean Liew, MD, MS; Jonathan Hausmann, MD; Rebecca Grainger, MB ChB, PhD; Monique Gore-Massy; & Suleman Bhana, MD, FACR |
We write to celebrate the life of Philip C. Robinson, MB ChB, PhD, FRACP, a beloved colleague and leader in rheumatology. Phil died in early January after an unexpected and short illness. He is survived by his wife, Helen, and his two young sons. We have witnessed an incredible outpouring of respect and affection for…
The new council, comprising professionals from small or independent rheumatology practices, will work with the ACR and its committees on issues that confront members in small practices.
The ACR highlights essential policy and reporting changes to the Quality Payment Program for performance year 2023 and beyond. Key changes include policies regarding the development of new MIPS Value Pathways and refinement of subgroup participation.
The new standing committee, devoted to addressing long-term workforce solutions in rheumatology, will be chaired by Daniel F. Battafarano, DO, MACP, MACR. Dr. Battafarano brings more than 35 years of leadership and experience in graduate medical education in rheumatology and internal medicine to the position.
Later this month, the Department of Health & Human Services (HHS) is expected to extend the public health emergency (PHE) for another 90 days. The PHE extension will allow for the continuation of many flexibilities instituted in 2020, including the expansion of such telehealth provisions as audio-only telehealth.